GLP-1 use during early pregnancy may not increase risk of major adverse outcomes | Harvard T.H. Chan School of Public Health
hsph.harvard.edu
Taking GLP-1s during the first trimester of pregnancy does not appear to increase the risk of major adverse outcomes such as non-live birth, according to a new Harvard Chan School study.
  • HubertManne@piefed.socialEnglish
    3·
    1 month ago

    boy this is one of those things where Im kinda paranoid until its been used for awhile. Granted I was a bit like that with laser eye surgery.